The anti‐tumourigenic effect of ellagic acid in SKOV‐3 ovarian cancer cells entails activation of autophagy mediated by inhibiting Akt and activating AMPK

Autor: Mohamed A. Alshehri, Ali S. Alsheri, Ehab El Sayed Massoud, Fahmy G. Elsaid, Haitham I. El‐Mekkawy, Amira M. Al‐Ramlawy, Ali A. Shati, Mohamed E. Abdraboh, Attalla F. El-kott, M.A. Al-Kahtani
Rok vydání: 2020
Předmět:
Zdroj: Clinical and Experimental Pharmacology and Physiology. 47:1611-1621
ISSN: 1440-1681
0305-1870
DOI: 10.1111/1440-1681.13338
Popis: This study investigated the effect of ellagic acid (EA) on SKOV-3 cell growth and invasiveness and tested if the underlying mechanism involves modulating autophagy. Cells were treated with EA in the presence or absence of chloroquine (CQ), an autophagy inhibitor, compound C (CC), an AMPK inhibitor, or an insulin-like growth factor-1 (IGF-1), a PI3K/Akt activator. EA, at an IC50 of 36.6 µmol/L, inhibited cell proliferation, migration, and invasion and induced cell apoptosis in SKOV-3 cells. These events were prevented by CQ. Also, EA increased levels of Beclin-1, ATG-5, LC3I/II, Bax, cleaved caspase-3/8 and reduced those of p62 and Bcl-2 in these cancer cells. Mechanistically, EA decreased levels of p-S6K1 (Thr389 ) and 4EBP-1 (Thr37/46 ), two downstream targets of mTORC1, and p-Akt (Thr308 ) but increased levels of AMPK (Thr172 ) and p-raptor (Ser792 ), a natural inhibitor of mTORC1. CC or IGF-1 alone partially prevented the effect of EA on cell survival, cell invasions, and levels of LDH, Beclin-1, and cleaved caspase-3. In conclusion, EA can inhibit SKOV-3 growth, migration, and invasion by activating cytotoxic autophagy mediated by inhibition of mTORC1 and Akt and activation of AMPK.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje